Cargando…

Epidemiological Study Assessing the Overuse of Proton Pump Inhibitors in Lebanese Population

BACKGROUND Proton pump inhibitors (PPIs) are the most potent gastric agents for most acid-related disorders. Their effectiveness has led to their overutilization, leading to potential risks on patients and significant economic implications. The aim of this study was to determine the frequency of PPI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoteit, Mayssaa, Mattar, Elham, Allaw, Racil, Abou Rached, Antoine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Association of Gastroerterology and Hepatology 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859611/ https://www.ncbi.nlm.nih.gov/pubmed/33564384 http://dx.doi.org/10.34172/mejdd.2020.192

Ejemplares similares

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Holistic management of symptomatic reflux: rising to the challenge of proton pump inhibitor overuse
por: Savarino, Edoardo, et al.
Publicado: (2022)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Assessment of Awareness and Knowledge of Proton Pump Inhibitors Among the General Population in Saudi Arabia
por: Aljahdli, Emad S, et al.
Publicado: (2022)

Multivariate epidemiologic analysis of type 2 diabetes mellitus risks in the Lebanese population
por: Ghassibe-Sabbagh, Michella, et al.
Publicado: (2014)

Are Proton Pump Inhibitors Contributing in Emerging New Hypertensive Population?
por: Tayal, Rohit, et al.
Publicado: (2023)

Prevalence and Risk Factors Associated With Inflammatory Bowel Disease in Patients Using Proton-Pump Inhibitors: A Population-Based Study
por: Onwuzo, Somtochukwu, et al.
Publicado: (2023)

Factors motivating lebanese youth to adopt COVID-19 good practices: a cross-sectional study
por: Bou-Hamad, Imad, et al.
Publicado: (2023)

Preoperative fasting: Assessment of the practices of Lebanese Anesthesiologists
por: Dagher, Christine, et al.
Publicado: (2019)

KIR genotype distribution among Lebanese patients with Hodgkin's lymphoma
por: Hoteit, Rouba, et al.
Publicado: (2015)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
por: Shah, Nigam H., et al.
Publicado: (2015)

Patients' perspectives on a patient-oriented electronic decision support tool to reduce overuse of proton pump inhibitors (arriba-PPI): a qualitative study in primary care
por: Schmidt, Alexandra, et al.
Publicado: (2023)

Is the Use of Proton Pump Inhibitors a Predisposing Factor for Pyogenic Liver Abscesses?
por: Elfiky, Ahmed, et al.
Publicado: (2021)

Assessment of the knowledge, attitudes and practices of Lebanese shoppers towards food labeling: The first steps in the Nutri-score roadmap
por: Hoteit, Maha, et al.
Publicado: (2022)

Assessment of Awareness and Knowledge of Proton Pump Inhibitors Among the General Population in the Qassim Region, Saudi Arabia
por: Almuzaini, Reema, et al.
Publicado: (2023)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

Epidemiology of Acute and Overuse Injuries in Underwater Rugby
por: Lutter, Christoph, et al.
Publicado: (2023)

Epidemiology and composition of nephrolithiasis in a Lebanese tertiary care center: A descriptive study
por: Degheili, Jad A., et al.
Publicado: (2022)

Epidemiology of Ocular Malignancies Among the Lebanese Population: A 12-Year Review
por: Akiki, Dany, et al.
Publicado: (2022)

Management of laryngopharyngeal reflux with proton pump inhibitors
por: Reimer, Christina, et al.
Publicado: (2008)

Proton Pump Inhibitor Induced Depigmentation in Vitiligo
por: Holla, Anantha Prasad, et al.
Publicado: (2011)

Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
por: Swaminathan, Krishnan
Publicado: (2015)

Proton pump inhibitors: A balanced view
por: Ramakrishna, B.S.
Publicado: (2015)

Proton Pump Inhibitors: The Culprit for Barrett’s Esophagus?
por: Alsalahi, Omran, et al.
Publicado: (2015)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Proton Pump Inhibitor-associated Mucosal Change
por: Kato, Mototsugu, et al.
Publicado: (2017)

Proton pump inhibitors induce hemolytic anemia
por: Al-Nasser, Asayil Nasser, et al.
Publicado: (2019)

When is proton pump inhibitor use appropriate?
por: Yadlapati, Rena, et al.
Publicado: (2017)

Use of proton pump inhibitors in general practice
por: Tosetti, Cesare, et al.
Publicado: (2017)

Effect of Proton Pump Inhibitors on Colorectal Cancer
por: Sasaki, Takamitsu, et al.
Publicado: (2020)

Problems Associated with Deprescribing of Proton Pump Inhibitors
por: Helgadottir, Holmfridur, et al.
Publicado: (2019)

Proton pump inhibitors in the COVID-19 pandemic()
por: Sebastián Domingo, Juan J.
Publicado: (2021)

The Association of Diuretics and Proton Pump Inhibitors With Chondrocalcinosis
por: Felson, David T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_940ssla638a866i98sms3ebq31